© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to May
selective BACE1 protease inhibitor
oral PD demonstrated on A_ in model
from optimization of prior ligand
Bioorg. Med. Chem. Lett., May 1, 2020
Amgen, Thousand Oaks, CA
“Compound 15” is a BACE1 selective inhibitor with a fluoro-olefin replacement for an N-aryl amide without the liability of a potential aniline metabolite. The compound has good oral PK in…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.